Skip to content

SUPPADERM: what changed

BE 0778.825.569NACE 86.220, Specialist medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€63,623
2024 · €49,459+€14,164
Equity
€5,064
2024 · €6,441-€1,377
Cash
€57,455
2024 · €96,042-€38,587
Balance sheet total
€100,194
2024 · €112,347-€12,153

Largest movements

2024 to 2025
Assets
  • Cash -€38,587

    down €38,587 (-40.2%), from €96,042 to €57,455

    mainly Contributions, distributions and other (-€65,000) and Investment in fixed assets (net) (-€15,300)

  • Financial fixed assets +€15,300

    up €15,300 (+1,106%), from €1,383 to €16,683

  • Receivables within one year +€13,435

    up €13,435 (+128%), from €10,498 to €23,933

    of which Other amounts receivable: +€13,795

  • Tangible fixed assets -€1,636

    down €1,636 (-49.0%), from €3,337 to €1,701

Equity and liabilities
  • Other debts -€10,750

    down €10,750 (-10.2%), from €105,164 to €94,414

  • Profit (loss) carried forward -€1,377

    down €1,377 (-34.9%), from €3,941 to €2,564

Income statement
  • Taxes -€13,067

    down €13,067 (-100%), from €13,067 to €0

  • Gross operating margin +€1,698

    up €1,698 (+2.7%), from €63,859 to €65,557

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €49,459
Gross operating margin +€1,698
Depreciation -€129
Financial income -€214
Financial charges -€258
Taxes +€13,067
Result 2025 €63,623
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€41,713
Investment -€15,300
Financing -€65,000
Cash 2024 €96,042
Net result for the year +€63,623
Depreciation +€1,636
Receivables within one year -€13,435
Deferred charges and accrued income +€664
Trade debts -€26
Other debts -€10,750
Investment in fixed assets (net) -€15,300
Contributions, distributions and other -€65,000
Cash 2025 €57,455
brings cash intakes cash out
Every line side by side 31 lines
Line Code 2024 2025 Change %
Total assets 20/58 €112,347 €100,194 -€12,153 -10.8%
Fixed assets 21/28 €4,720 €18,384 +€13,664 +289%
Tangible fixed assets 22/27 €3,337 €1,701 -€1,636 -49.0%
Furniture and vehicles 24 €3,337 €1,701 -€1,636 -49.0%
Financial fixed assets 28 €1,383 €16,683 +€15,300 +1,106%
Current assets 29/58 €107,626 €81,810 -€25,816 -24.0%
Amounts receivable within one year 40/41 €10,498 €23,933 +€13,435 +128%
Trade receivables 40 €360 €0 -€360 -100%
Other amounts receivable 41 €10,138 €23,933 +€13,795 +136%
Cash at bank and in hand 54/58 €96,042 €57,455 -€38,587 -40.2%
Deferred charges and accrued income 490/1 €1,086 €422 -€664 -61.2%
Total equity and liabilities 10/49 €112,347 €100,194 -€12,153 -10.8%
Equity 10/15 €6,441 €5,064 -€1,377 -21.4%
Contributions 10/11 €2,500 €2,500 = 0.0%
Profit (loss) carried forward 14 €3,941 €2,564 -€1,377 -34.9%
Amounts payable 17/49 €105,906 €95,130 -€10,776 -10.2%
Amounts payable within one year 42/48 €105,906 €95,130 -€10,776 -10.2%
Trade debts 44 €742 €716 -€26 -3.5%
Suppliers 440/4 €742 €716 -€26 -3.5%
Other amounts payable 47/48 €105,164 €94,414 -€10,750 -10.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,508 €1,636 +€129 +8.5%
Gross operating margin 9900 €63,859 €65,557 +€1,698 +2.7%
Operating profit (loss) 9901 €62,351 €63,921 +€1,570 +2.5%
Financial income 75/76B €215 €1 -€214 -99.6%
Recurring financial income 75 €215 €1 -€214 -99.6%
Financial charges 65/66B €40 €298 +€258 +644%
Recurring financial charges 65 €40 €298 +€258 +644%
Profit (loss) for the period before taxes 9903 €62,526 €63,623 +€1,098 +1.8%
Income taxes 67/77 €13,067 €0 -€13,067 -100%
Profit (loss) for the period 9904 €49,459 €63,623 +€14,164 +28.6%
Profit (loss) for the period to be appropriated 9905 €49,459 €63,623 +€14,164 +28.6%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€187,596 to €261,622

Midpoint €218,440 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €5,064
Capitalised earnings €370,129 to €518,180
Indication €187,596 to €261,622

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€5,064
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€5,064

Capitalised earnings

net result for the year (9904)
2025
€63,623
2024
€49,459
2023
€42,372
2022
€18,528
2021
-€1,417
Average result
€51,818
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€370,129 / €431,817 / €518,180

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 16 November 2026 via checked.be.